About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Equity Capital Raising Placement of New Shares

September 1, 2014

Click here to read more

Post navigation

Financial Report for Half Year ended 30 June 2014

Phosphagenics Announces Successful Results from its Phase 2 TPM®/Tretinoin Gel Study on Acne Patients

Related Posts

New Agreement with Medterra Pharma

December 20, 2021December 20, 2021

Ashland Purchases Manufacturing Rights for VitalET and TPM

June 20, 2019August 28, 2019

Quarterly Activities Report and 4C

July 27, 2021July 27, 2021

Recent Posts

New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025
Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.